Antifungal Treatment Market is Expected to Grow at a CAGR of 4.61% From 2017 To 2023

Market Research Future has a cooked research report on the global antifungal treatment market. The global antifungal treatment market is expected to grow at a CAGR of 4.61% from 2017 to 2023.

Antifungal Treatment Market Information, By Drugs Class (Azoles, Pyrimidines, Echinocandins, Polyenes, Allylamines, And Others), By Therapeutic Indication (Systemic, Candidiasis, Coccidioidomycosis, Cryptococcosis, And Prophylactic), By Pathogen (Candida, Aspergillus, Cryptococcus, Coccidioides Immitis, Zygomycetes, Trichophyton, And Others), And By End Users (Hospitals & Clinics, Dermatology Clinics, And Others) – Global Forecast Till 2023

The global antifungal treatment market is growing moderately and expected to grow at the same pace over the forecast period 2017-2013. Increasing number of patients with fungal diseases and growing prevalence of HIV are the key factors of the market growth. Additionally, rising geriatric population is one of the important drivers of the market growth.  

The global Antifungal treatment market is expected to grow at a CAGR of 4.61% during the forecast period and is estimated to reach USD 19,558.0 million by 2023.

Taste the market data and market information presented through more than 80 market data tables and figures spread over 108 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “anti-fungal treatment market research report–Global forecast till 2023.”

Get a sample copy @ . 

Regional Analysis

The global antifungal treatment market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominate this market, particularly, North America due to increasing cases of patients with fungal infections in this region. Furthermore, rapid adoption of new antifungal treatment methods and developed healthcare infrastructure propel the growth of the market.

Rising prevalence of fungal diseases is driving the growth of the European market. Most of the European companies are focusing more on research and development of the antifungal drugs, which, in turn, fortify their position in the global market. These companies receive a government funding from the government, which favors the growth of market in Europe.

Asia Pacific is expected to be the fastest growing region in this market owing to the developing healthcare infrastructure, increasing adoption of new medical practices, rising healthcare expenditure, growing awareness about available treatments for fungal infections.

The Middle East & Africa region is expected to grow slower than the global average due to lack of awareness about antifungal treatments and limited access to healthcare facilities.


The global antifungal treatment market has been segmented on the basis of drugs class, which includes azoles, pyrimidines, echinocandins, polyenes, allylamines, and others drugs.

On the basis of therapeutic indication, the market is segmented into systemic, candidiasis, coccidioidomycosis, and cryptococcosis.

On the basis of pathogen, the market is segmented into CandidaAspergillusCryptococcusCoccidioides immitisZygomycetes, Trichophyton, and others.

On the basis of end users, the market is segmented into hospitals & clinics, dermatology clinics and other users.

Major Players

Some of the key players in this market are Novartis AG (Switzerland), Pfizer Inc. (U.S), Sanofi (France), Merck & Co., Inc. (U.S), Astellas (Japan), Bayer AG (Germany)

Complete Report Available at .

Regional Analysis of Global Antifungal Treatment Market  
Considering the global scenario of the market, the Americas accounted for a significant market share in 2016, which was valued at USD 5,539.4 million as a result of increasing prevalence of immunological diseases and rising healthcare expenditure.

Europe is the second largest market and holds a noticeable share in the global antifungal treatment market. The European market is expected to grow significantly during the forecast period owing to availability of advanced treatment facilities, skilled medical professionals, and adoption of new therapies.

Increasing prevalence of HIV in Asia Pacific region is the key factor for the market growth. Rising awareness about the antifungal treatment and availability of new treatment methods drive the market in Asia Pacific region. In Asia Pacific, the market shows growth opportunities in China and India. China is expected to be the fastest growing market with the CAGR of 5.24% during the forecasted period.

The Middle East & Africa is expected to show the least growth in this market due to some major factors such as lack of awareness about the anti-fungal treatment, limited access and availability of treatment facilities, low income etc.

Get a Discount at .

Key Findings

  • Azoles segment in drug class held the largest market share in 2016, which was valued at USD 2,312.6 million in 2016
  • Systemic segment in therapeutics indication held the largest market share in 2016.
  • Asia Pacific region is expected to be the fastest growing market at the CAGR of 4.88% during the forecasted period.

The report on the Global Anti-fungal Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions


Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India